All Stories

As FDA's Peter Marks resigns, industry watchers eye vaccine, cell and gene therapy hits

In resigning as director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., blast the promotion of vaccine disinformation under new HHS secretary Robert F. Kennedy Jr.

Mar 31, 2025 - 15:59
 0
As FDA's Peter Marks resigns, industry watchers eye vaccine, cell and gene therapy hits
In resigning as director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., blast the promotion of vaccine disinformation under new HHS secretary Robert F. Kennedy Jr.
Read More

Tags:

Previous Article

Test Rocket Explodes Seconds After Europe's First Orbital Rocket Launch

Next Article

Human medicines European public assessment report (EPAR): Locametz, gozetotide, ...

Related Posts

Roche scores FDA nod for Evrysdi tablets, bolstering convenience edge over rivals

Roche scores FDA nod for Evrysdi tablets, bolstering co...

Feb 13, 2025  0

Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad

Merck KGaA's EMD Serono taps Selma Blair to join long-r...

Feb 20, 2025  0

Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035

Novartis pumps $7.5M into push to save 100,000 lives fr...

Feb 19, 2025  0